Alterations of the TP53 Gene in Human Gliomas

Cancer Research

Volumn 54, Issue 5, 1994, Pages 1324-1330

  Friedman, Allan H ^a   McLendon, Roger E ^a   Signer, Darell D ^a   Bigner, Sandra H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 10Q; CHROMOSOME 17P; EPENDYMOMA; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GLIOBLASTOMA; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; OLIGODENDROGLIOMA; ONCOGENE C MYB; ONCOGENE C MYC; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, P53; GLIOMA; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION;

EID: 0028198314     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Levine, A., Momand., J., and Finlay, C.A. The p. 3 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutation in human cancers. Science (Washington DC), 253: 49-53, 1991.
3. Moll, U.M., Riou, G., and Levine, A.J. Two distinct mechanisms alter p. 3 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA, 89: 7262-7266, 1992.
4. Vogelstein, B., and Kinzler, K.W. p. 3 function and dysfunction. Cell, 70: 523-526, 1992.
5. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., and Friend, S.H. Germ line p. 3 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
6. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E.H. Germ-line transmission of a mutated p. 3 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (Lond.), 348: 747-749, 1990.
7. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
8. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
9. de Fromentel, C.C., and Soussi, T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chrom. Cancer, 4: 1-15, 1992.
10. Spruck, C.H., Rideout, W.M., Olumi, A.F., Ohneseit, P.F., Yang A.S., Tsai, Y.C., Nichols, P.W., Horn, T., Hermann, G.G., Steven, K., Ross, R.K., Yu, M.C., and Jones, P.A. Distinct pattern of p. 3 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53: 1162-1166, 1993.
11. Moles, J.P., Moyret, C., Guillot, B., Jeanteur, P., Guilhou, J.J., Theillet, C., and Basset-Seguin, N. p. 3 Gene mutations in human epithelial skin cancers. Oncogene, 8: 583-588, 1993.
12. Nigra, J., Baker, S.J., Presisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C., and Vogetstein, B. Mutations in the p. 3 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
13. Mashiyama, S., Murakami, Y., Yoshimoto, T., Sekiya, T., and Hayashi, K. Detection of p. 3 gene mutations in human brain tumors by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 6: 1313-1318, 1991.
14. Chung, R., Whaley, J., Kley, N., Anderson, K., Louis, D., Menon, A., Hettlich, C., Freiman, R., Hedley-White, E.T., Martuza, R., Jenkins, R., Yandell, D., and Seizinger, B. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chrom. Cancer, 3: 323-331, 1991.
15. Ohgaki, H., Eibl, R.H., Wiestler, O.D., Yasargil, M.G., Newcomb, E.W., and Kleihues, P. p. 3 Mutations in nonastrocytic human brain tumors. Cancer Res., 51: 6202-6205, 1991.
16. Fults, D., Brockmeyer, D., Tullous, M.W., Pedone, C.A., and Cawthon, R. p. 3 Mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
17. Frankel, R.H., Bayona, W., Koslow, M., and Newcomb, E.W. p. 3 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res., 52: 1427-1433, 1992.
18. von Deimling, A., Eibl, R.H., Ohgaki, H., Louis, D.N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R.Y., and Seizinger, B.R. p. 3 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
19. Saxena, A., Clark, W.C., Robertson, J.T., Ikejiri. B., Oldfield, E.H., and Ali, I.U. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p. 3 in malignant astrocytomas. Cancer Res., 52: 6716-6721, 1992.
20. Louis, D.N., von Deimling, A., Chung, R.Y., Rubio, M.P., Whaley, J.M., Eibl, R.H., Ohgaki, H., Weistler, O.D., Thor, A.D., and Seizinger, B.R. Comparative study of p. 3 gene and protein alterations in human astrocytic tumors. J Neuropathol. Exp. Neurol., 52: 31-38, 1993.
21. Zulch, K.J. Histological Typing of Tumors of the Central Nervous System. Geneva: WHO, 1979.
22. Rasheed, B.K.A., Fuller, G.N., Friedman, A.H., Bigner, D.D., and Bigner, S.H. Loss of heterozygosity for lOq loci in human gliomas. Genes Chrom. Cancer, 5: 75-82, 1992.
23. Bigner, S.H., Friedman, H.S., Vogelstein, B., Oakes, W.J., and Bigner, D.D. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res., 50: 2347-2350, 1990.
24. Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Pierce, J., and Aaronson S. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science (Washington DC) 243: 800-804, 1989.
25. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L., and Vogelstein, B. Amplification of a gene encoding p. 3-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
26. Buchman, V.L., Chumakov, P.M., Ninkina, N.N., Samarina, O.P., and Georgiev, G.P. A variation in the structure of the protein-coding region of the human p. 3 gene. Gene, 70: 245-252, 1988.
27. Spinardi, L., Mazars, R., and Theillet, C. Protocols for an improved detection of point mutations by SSCP. Nucleic Acids. Res. 19: 4009, 1991.
28. Rasheed, B.K.A., and Bigner, S.H. Genetic alterations in glioma and medulloblastoma. Cancer Metastas. Rev., 10: 289-299, 1991.
29. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E.E., and Collins, V.P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p. 3 mutations. Cancer Res., 53: 2736-2739, 1993.
30. von Deimling, A., Louis, D.N., von Ammon, K., Petersen, I., Seizinger, B.R., and Wiestler, O.D. Molecular genetic evidence for two distinct subsets of glioblastoma multiforme (Abstract). Clin. Neuropathol., 11: 265-266, 1992.
31. Bigner, S.H., Mark, J., Burger, P.C., Mahaley, M.S., Bullard, D.E., Muhlbaier, L.H., and Bigner, D.D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res., 88: 405-411, 1988.
32. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M.L., Cavanee, W., and Vogelstein, B. Clonal expansion of p. 3 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.